AmeriCare Home Health has been acquired by Brooks Rehabilitation
The private shareholders of AmeriCare Home Health (AmeriCare) have sold the company to Brooks Rehabilitation. Financial details have not been disclosed.
AmeriCare is a leading provider of home healthcare services including skilled nursing, physical therapy, occupational therapy, speech therapy, social work, home health aide, and private duty. The company is headquartered in Jacksonville, Florida, and operates 10 satellite office locations serving 23 counties in northeast and central Florida.
Brooks Rehabilitation is a recognized leader in providing a system of world class rehabilitation services. It operates an inpatient hospital providing rehabilitation and medical care for people requiring intensive inpatient therapy, 26 outpatient clinics, as well as Brooks Home Care which serves northeast Florida.
Oaklins' team in Jacksonville acted as financial advisor and intermediary to the seller in this transaction.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more